These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3291008)
1. [Sequential or alternate chemo-radiotherapy in the treatment of advanced head and neck tumors. Results of a randomized study]. Corvò R; Merlano M; Scarpati D; Grimaldi A; Benasso M; Franzone P; Santelli A; Scasso F; Rosso R; Vitale V Radiol Med; 1988 Jun; 75(6):653-9. PubMed ID: 3291008 [TBL] [Abstract][Full Text] [Related]
2. Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study. Merlano M; Rosso R; Sertoli MR; Bonelli L; Margarino G; Grimaldi A; Benasso M; Gardin G; Corvó R; Scarpati D J Clin Oncol; 1988 Apr; 6(4):627-32. PubMed ID: 2451713 [TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck. Merlano M; Rosso R; Sertoli MR; Benasso M; Bacigalupo A; Ardizzoni A; Mereu P; Margarino G; Scala M; Vitale V Laryngoscope; 1990 May; 100(5):531-5. PubMed ID: 1691811 [TBL] [Abstract][Full Text] [Related]
4. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Merlano M; Corvo R; Margarino G; Benasso M; Rosso R; Sertoli MR; Cavallari M; Scala M; Guenzi M; Siragusa A Cancer; 1991 Feb; 67(4):915-21. PubMed ID: 1703916 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities]. Klima A; von Ilberg C; Bergmann L; Zoubek A; Klippstein T; Mitrou PS; Szepesi S HNO; 1987 Feb; 35(2):78-83. PubMed ID: 2437086 [TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Laramore GE; Scott CB; al-Sarraf M; Haselow RE; Ervin TJ; Wheeler R; Jacobs JR; Schuller DE; Gahbauer RA; Schwade JG Int J Radiat Oncol Biol Phys; 1992; 23(4):705-13. PubMed ID: 1618662 [TBL] [Abstract][Full Text] [Related]
8. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. Fu KK; Phillips TL; Silverberg IJ; Jacobs C; Goffinet DR; Chun C; Friedman MA; Kohler M; McWhirter K; Carter SK J Clin Oncol; 1987 Sep; 5(9):1410-8. PubMed ID: 2442323 [TBL] [Abstract][Full Text] [Related]
9. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161 [TBL] [Abstract][Full Text] [Related]
10. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Katori H; Tsukuda M; Watai K Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160 [TBL] [Abstract][Full Text] [Related]
11. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community. Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423 [TBL] [Abstract][Full Text] [Related]
12. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival. Slotman GJ; Doolittle CH; Glicksman AS Cancer; 1992 Jun; 69(11):2736-43. PubMed ID: 1571903 [TBL] [Abstract][Full Text] [Related]
13. Multidrug chemotherapy (vincristine, bleomycin, and methotrexate [VBM]) with radiotherapy in stage III-IV squamous cell carcinoma of the head and neck. Rosso R; Merlano M; Sertoli MR; Campora E; Scarpati D; Borasi F; Pallestrini E Cancer Treat Rep; 1984; 68(7-8):1019-21. PubMed ID: 6204753 [TBL] [Abstract][Full Text] [Related]
14. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526 [TBL] [Abstract][Full Text] [Related]
15. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):567-76. PubMed ID: 7790241 [TBL] [Abstract][Full Text] [Related]
16. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. Jacobs C; Makuch R J Clin Oncol; 1990 May; 8(5):838-47. PubMed ID: 2185340 [TBL] [Abstract][Full Text] [Related]
18. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901 [TBL] [Abstract][Full Text] [Related]
19. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053 [TBL] [Abstract][Full Text] [Related]
20. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]